INDP: Indaptus Therapeutics Inc
今日INDP汇率已更改1.79%。当日,交易品种以低点1.8901和高点2.1000进行交易。
关注Indaptus Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M15
- M30
- H1
- H4
- D1
- W1
- MN
INDP新闻
- Indaptus Therapeutics调整高管薪资,董事会成员撤回辞职决定
- Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation
- Indaptus Therapeutics任命David Natan加入董事会和审计委员会
- Indaptus Therapeutics appoints David Natan to board and audit committee
- Indaptus Therapeutics股价在600万美元证券交易后下跌
- Indaptus Therapeutics stock falls after $6 million securities deal
- Indaptus Therapeutics获得600万美元投资并任命新董事长
- Indaptus Therapeutics secures $6 million investment, names new chairman
- Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Indaptus Therapeutics (NASDAQ:INDP), Kala Bio (NASDAQ:KALA)
- Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - American Battery Tech (NASDAQ:ABAT), Achieve Life Sciences (NASDAQ:ACHV)
- U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.48%
- Indaptus Therapeutics stock falls after mixed clinical trial updates
- Indaptus reports partial response in cancer patient with Decoy20
- Indaptus Posts Narrower Loss in Q2
- Indaptus Therapeutics regains compliance with Nasdaq minimum bid price rule
- Indaptus Therapeutics raises $5.7 million through convertible notes
- Indaptus Therapeutics approves 1-for-28 reverse stock split
- Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results - Compass Pathways (NASDAQ:CMPS), Cidara Therapeutics (NASDAQ:CDTX)
- Why Sequans Communications Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarket - Compass Pathways (NASDAQ:CMPS), Citius Oncology (NASDAQ:CTOR)
- Indaptus Therapeutics raises $2.3 million through convertible notes
- Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
- INDP stock touches 52-week low at $0.31 amid sharp annual decline
- Indaptus Therapeutics Q1 Update: Company Advances Decoy20 Immunotherapy To Fight Cancer, Maxim Group Analyst Reiterates Buy Rating - Indaptus Therapeutics (NASDAQ:INDP)
- EXCLUSIVE: Indaptus Therapeutics Starts Phase 1 Combination Study of Decoy20 With BeiGene's Cancer Drug For Advanced Solid Tumors - Indaptus Therapeutics (NASDAQ:INDP)
常见问题解答
INDP股票今天的价格是多少?
Indaptus Therapeutics Inc股票今天的定价为2.1000。它在1.8901 - 2.1000范围内交易,昨天的收盘价为2.0630,交易量达到22。INDP的实时价格图表显示了这些更新。
Indaptus Therapeutics Inc股票是否支付股息?
Indaptus Therapeutics Inc目前的价值为2.1000。股息政策取决于公司,而投资者也会关注10.53%和USD。实时查看图表以跟踪INDP走势。
如何购买INDP股票?
您可以以2.1000的当前价格购买Indaptus Therapeutics Inc股票。订单通常设置在2.1000或2.1030附近,而22和1.94%显示市场活动。立即关注INDP的实时图表更新。
如何投资INDP股票?
投资Indaptus Therapeutics Inc需要考虑年度范围1.8001 - 2.1799和当前价格2.1000。许多人在以2.1000或2.1030下订单之前,会比较1.94%和。实时查看INDP价格图表,了解每日变化。
Indaptus Therapeutics Inc股票的最高价格是多少?
在过去一年中,Indaptus Therapeutics Inc的最高价格是2.1799。在1.8001 - 2.1799内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Indaptus Therapeutics Inc的绩效。
Indaptus Therapeutics Inc股票的最低价格是多少?
Indaptus Therapeutics Inc(INDP)的最低价格为1.8001。将其与当前的2.1000和1.8001 - 2.1799进行比较,可以发现潜在的长期切入点。观看INDP在图表上的实时走势以获取更多详细信息。
INDP股票是什么时候拆分的?
Indaptus Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、2.0630和10.53%中可见。
- 前一天收盘价
- 2.0630
- 开盘价
- 2.0600
- 卖价
- 2.1000
- 买价
- 2.1030
- 最低价
- 1.8901
- 最高价
- 2.1000
- 交易量
- 22
- 日变化
- 1.79%
- 月变化
- 1.94%
- 6个月变化
- 10.53%
- 年变化
- 10.53%